SCYNEXIS Stock

SCYNEXIS Days Payable Outstanding

Days Payable Outstanding (DPO) of SCYNEXIS (SCYX) as of Aug 8, 2026.

Days Payable Outstanding

0.00

Last updated:

Days Payable Outstanding (DPO) of SCYNEXIS is 2026 0.00 . Days Payable Outstanding (DPO) of SCYNEXIS was 2025 167.01 . It decreases by % lower compared to the previous year.
Access this data via the Eulerpool API

SCYNEXIS Stock analysis

What does SCYNEXIS do? SCYNEXIS Inc is a biopharmaceutical company that focuses on the discovery and development of novel therapeutics for serious infectious diseases and cancer. The company was founded in 2000 and is headquartered in New Jersey, USA. SCYNEXIS is one of the most popular companies on Eulerpool.

Frequently Asked Questions about SCYNEXIS stock

On Eulerpool you can find the complete historical development of Days Payable Outstanding (DPO) SCYNEXIS since 2006 – with annual values, charts, and detailed analysis.

DPO measures the average number of days a company takes to pay its suppliers. Higher DPO can improve cash flow but may strain supplier relationships.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Days Payable Outstanding (DPO)'s SCYNEXIS with sector peers and the industry average to assess whether it is attractive.

To evaluate Days Payable Outstanding (DPO)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Days Payable Outstanding (DPO).

Access this data via the Eulerpool API

Profitability — SCYNEXIS

All Key Metrics — SCYNEXIS